Pages that link to "Q33862414"
Jump to navigation
Jump to search
The following pages link to A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder (Q33862414):
Displaying 50 items.
- Prospective open-label study of add-on and monotherapy topiramate in civilians with chronic nonhallucinatory posttraumatic stress disorder (Q21260296) (← links)
- Pharmacotherapy for post-traumatic stress disorder: systematic review and meta-analysis (Q22255551) (← links)
- World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Posttraumatic Stress Disorders (Q22305681) (← links)
- Newer anticonvulsants in the treatment of anxiety disorders (Q24244717) (← links)
- Pharmacotherapy for post traumatic stress disorder (PTSD) (Q24244802) (← links)
- Review of the use of Topiramate for treatment of psychiatric disorders (Q24523918) (← links)
- Psychopharmacotherapy of posttraumatic stress disorder (Q24657148) (← links)
- Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: a systematic review (Q24657469) (← links)
- The treatment of generalized anxiety disorder with pregabalin, an atypical anxiolytic (Q24658278) (← links)
- Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders (Q27009995) (← links)
- Targeting memory processes with drugs to prevent or cure PTSD (Q27016155) (← links)
- A selective review of glutamate pharmacological therapy in obsessive-compulsive and related disorders (Q28082048) (← links)
- The effectiveness of anticonvulsants in psychiatric disorders (Q28744504) (← links)
- Region-specific alteration in brain glutamate: possible relationship to risk-taking behavior. (Q30381682) (← links)
- Advances in the treatment of anxiety: targeting glutamate (Q30457479) (← links)
- Pharmacotherapy of PTSD: premises, principles, and priorities (Q30479154) (← links)
- A randomized, double-blind, placebo-controlled trial to assess the efficacy of topiramate in the treatment of post-traumatic stress disorder (Q30488880) (← links)
- Effects of traumatic stress on brain structure and function: relevance to early responses to trauma (Q33223009) (← links)
- Selective serotonin reuptake inhibitors in post-traumatic stress disorder (Q33886709) (← links)
- Pharmacotherapy for posttraumatic stress disorder: empirical review and clinical recommendations (Q33988963) (← links)
- Pharmacotherapy for posttraumatic stress disorder (Q34062435) (← links)
- Tailoring therapeutic strategies for treating posttraumatic stress disorder symptom clusters (Q34122994) (← links)
- A psychopharmacological treatment algorithm for generalised anxiety disorder (GAD) (Q34183517) (← links)
- Post-traumatic stress disorder: a review of recent findings (Q34317705) (← links)
- Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology (Q34465555) (← links)
- Post-traumatic stress disorder: a review of psychobiology and pharmacotherapy. (Q34487670) (← links)
- Long-term pharmacotherapy for post-traumatic stress disorder (Q34531930) (← links)
- HCN Channel Targets for Novel Antidepressant Treatment. (Q34557298) (← links)
- The effectiveness of mirtazapine in the treatment of post-traumatic stress disorder: a 24-week continuation therapy (Q34651514) (← links)
- Update: new uses for lithium and anticonvulsants (Q34710521) (← links)
- Circuits and systems in stress. II. Applications to neurobiology and treatment in posttraumatic stress disorder (Q34803895) (← links)
- World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision (Q34865036) (← links)
- Post-traumatic Stress Disorder Symptoms in a Female Patient Following Repeated Teasing: Treatment with Gabapentin and Lamotrigine and the Possible Role of Sensitization. (Q34942758) (← links)
- Lamotrigine in the treatment of bipolar disorder (Q34974841) (← links)
- Psychopharmacological treatment in PTSD: a critical review (Q34977242) (← links)
- Post-traumatic stress disorder: emerging concepts of pharmacotherapy (Q34981801) (← links)
- Molecular targets in the treatment of anxiety (Q35001313) (← links)
- Gabapentin and Posttraumatic Stress Disorder (Q35112375) (← links)
- An Open-Label Trial of Memantine for Cognitive Impairment in Patients with Posttraumatic Stress Disorder (Q35646546) (← links)
- WCA Recommendations for the long-term treatment of posttraumatic stress disorder. (Q35651404) (← links)
- SSRIs versus non-SSRIs in post-traumatic stress disorder: an update with recommendations (Q35669835) (← links)
- Pharmacotherapy of anxiety disorders: a critical review (Q35686859) (← links)
- Current status of the utilization of antiepileptic treatments in mood, anxiety and aggression: drugs and devices (Q35757913) (← links)
- Noradrenergic vs serotonergic antidepressant with or without naltrexone for veterans with PTSD and comorbid alcohol dependence (Q35760199) (← links)
- Treatment-resistant posttraumatic stress disorder: strategies for intervention (Q35901891) (← links)
- Antiepileptic drugs in the treatment of anxiety disorders: role in therapy (Q35904830) (← links)
- Choosing antiepileptic drugs for developmentally normal children with specific epilepsy syndromes and behavioral disorders (Q35939596) (← links)
- Posttraumatic stress disorder in patients with bipolar disorder: a review of prevalence, correlates, and treatment strategies (Q38637312) (← links)
- Pharmacotherapy of post-traumatic stress disorder: a family practitioners guide to management of the disease (Q36106785) (← links)
- Post-traumatic stress disorder in women: epidemiological and treatment issues (Q36133824) (← links)